Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 172
Infectious Diseases Drugs 134
Genomics 106
Liver and Kidney Disorders Drugs 72
Drug Discovery 64
Immune Disorders Drugs 61
Pharmaceuticals 51
Cardiovascular Drugs 50
Biopharmaceuticals 46
Biotechnology 41
Leukemia Drugs 38
HIV/AIDS Drugs 36
Clinical Trials 33
Lymphoma Drugs 30
Respiratory Drugs 29
Musculoskeletal Disorders Drugs 29
Allergy and Immunology 28
Enzymes 26
Pulmonary Medicine 24
Oncology 22
Central Nervous System Drugs 19
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 18
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 13
Hematological Drugs 12
Diagnostics 11
Endocrine and Metabolic Disorders Drugs 11
Hematology 10
Sexual and Reproductive Health Drugs 10
Therapeutic Area 9
Healthcare Services 9
Antibiotics 9
Pharmaceutical Intermediates 8
Optical Disorders Drugs 8
Stem Cells 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Company Reports 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
In Vitro Diagnostics 2
Blood Banking 2
Medical Devices 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

1,070 Results (Page 29 of 54)
- Relevance
  Sort by

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

 Report
April 2025
220 Pages
Global

From

€1753EUR$1,997USD£1,525GBP

Global Markets for Infectious Disease Treatments

 Report
July 2025
186 Pages
Global

From

€4082EUR$4,650USD£3,551GBP

Stem Cell Therapy Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies

 Report
January 2025
363 Pages
Global

From

€4213EUR$4,799USD£3,665GBP

New Drug Delivery Systems Market 2025-2029

 Report
April 2025
221 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

 Report
November 2024
716 Pages
Global

From

€4213EUR$4,799USD£3,665GBP

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
September 2025
385 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology and Market Forecast - 2032

 Report
March 2024
257 Pages
Global

From

€6585EUR$7,500USD£5,727GBP

Antibody Drug Conjugates Market Report 2025-2035

 Report
December 2024
342 Pages
Global

From

€5176EUR$6,102USD£4,350GBP

Gastrointestinal Therapeutics - Global Strategic Business Report

 Report
September 2025
193 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

Fungal Keratitis Treatment Market 2024-2028

 Report
September 2024
170 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Postpartum Depression Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides

 Report
September 2025
262 Pages
Global

From

€6141EUR$6,995USD£5,342GBP

Atrial Fibrillation Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
91 Pages
Global

From

€3500EUR$4,271USD£3,151GBP

DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035

 Report
October 2023
278 Pages
Global

From

€4213EUR$4,799USD£3,665GBP

Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
November 2023
250 Pages
Global

From

€2151EUR$2,450USD£1,871GBP

Central Nervous System Collaboration and Licensing Deals 2020-2025

 Report
April 2025
400 Pages
Global

From

€3507EUR$3,995USD£3,051GBP

Autologous Stem Cell & Non-Stem Cell Based Therapies Market - Global Forecast 2024-2030

 Report
March 2024
180 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Tyrosine Kinase Inhibitors - Global Strategic Business Report

 Report
September 2025
290 Pages
Global

From

€5136EUR$5,850USD£4,467GBP

1,070 Results (Page 29 of 54)
- 1
- 27
- 28
- 29
- 30
- 31

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.